Concepedia

Richard Stebbings

RS

Statistics

Publications

36

Citations

1.8K

H-Index

24

Active since

1985

Affiliations

National Institute for Biological Standards and Control(Current)

AstraZeneca (United Kingdom)

National Institute of Standards and Technology

Melbourn Science Park

Center for Devices and Radiological Health

Richard Stebbings is an author at National Institute for Biological Standards and Control specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

1985–2022

36

Publications

36

“Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics

Richard Stebbings, Lucy Findlay, Cherry Edwards et al. · The Journal of Immunology · 2007 · 310 citations · Full text

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 <sup>+</sup> effector memory T‐cells

David Eastwood, Lucy Findlay, Stephen Poole et al. · British Journal of Pharmacology · 2010 · 283 citations · Full text

Evasion of Cytotoxic T Lymphocyte (CTL) Responses by <i>Nef</i>-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells

Xiao-Ning Xu, Gavin Screaton, Frances Gotch et al. · The Journal of Experimental Medicine · 1997 · 192 citations · Full text

Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412

Lucy Findlay, David Eastwood, Richard Stebbings et al. · Journal of Immunological Methods · 2009 · 75 citations

, , +9

After TGN1412: Recent developments in cytokine release assays

Richard Stebbings, David Eastwood, Stephen Poole et al. · Journal of Immunotoxicology · 2012 · 70 citations

1–5 of 36